Substance-Induced Anxiety Disorder Derek S. Mongold MD.

Slides:



Advertisements
Similar presentations
Substance Related Disorders
Advertisements

DSM – 5 Substance-Related and Addictive Disorders
A N X I E T Y VICTORIA PEARSON THERE ARE 14 DISORDERS CONTAINED IN THE DSM IV TR SECTION OF ANXIETY DISORDERS Panic Attack Agoraphobia Panic Disorder.
 They affect over 50 million people over age 18 in the United States  Many have a median onset as early as 13 years of age  Indirect and direct economic.
Cognitive Disorders Madiha Anas Institute of Psychology Beaconhouse National University.
Panic Disorder Heidi Catalan Mrs. Marsh Psychology Period 4.
Separation Anxiety Disorder (SAD) By Samuel Mejia P.1.
Adjustment Disorders Dr. Paul F. Hard, LPC-S, NCC.
Structure of the DSM IV-TR 5 AXES Axis I-- Clinical Disorders (other conditions) Axis II – Personality Disorders & Mental Retardation Axis III – General.
©2010 McGraw-Hill Higher Education. All rights reserved. Chapter 4 Definitions of Substance Abuse, Dependence, and Addiction.
North Carolina TASC Clinical Series Training Module Eight: DSM -IV.
Assessment of Substance Use Disorders
Lab 8 Anxiety Disorders. DSM IV Criteria Generalized Anxiety Disorder A) Excessive anxiety & worry (apprehensive expectation) occuring more days than.
Schizophrenia and Substance Use Disorders
General Anxiety Disorder (GAD) Generalized anxiety disorder (GAD) is an anxiety disorder that is characterized by excessive, uncontrollable and often.
An Overview. What is ODD? According to the Diagnostic and Statistical Manual of Mental Disordesr, 4 th Edition, Oppositional Defiant Disorder (ODD) is.
Separation Anxiety Disorder
DSM-5 ™ in Action: Diagnostic and Treatment Implications Section 2, Chapters 5–13 PART 2 of Section 2 Chapters 8–16 by Sophia F. Dziegielewski, PhD, LCSW.
Terms & Definitions Samhsa’s Co-Occurring Center for Excellence COCE.
Anxiety Disorders. Fundamental Features of Anxiety Disorders Fear and Threat Fear and Threat Effortful Avoidance Effortful Avoidance Compulsions or Rituals.
Bipolar Disorder and Substance Use Disorders Bipolar I Disorder Includes one or more Manic Episodes or Mixed Episodes, sometimes with Major Depressive.
Charles Hart Enzer, M.D Kugler Mill Road Cincinnati, OH WebSite:
Nor Firdous Mohamed Psychology and Counseling Department FPPM, UPSI.
Somatization Disorder Derek S. Mongold MD. DSM-IV TR Criteria A. A history of many physical complaints beginning before age 30 years that occur over a.
Substance abuse. Definition It’s a mental disorder that shows symptoms and maladaptive behavioral changes with the use of substances that affect the CNS.
Hyo Jae Shin.  Disruption in functioning of the mind  Conscious awareness becomes separated from previous thoughts and feelings  Mainly due to traumatic,
Undifferentiated Somatoform Disorder Derek S. Mongold MD.
Hypochondriasis: A somatoform disorder in which a person interprets normal physical sensations as symptoms of a disease or serious illness.
Treatment of Generalized Anxiety Disorder – Evidence Reconsidered Prof.R.N.Mohan Consultant Psychiatrist and Associate Medical Director and Director of.
Avoidant Personality Disorder Derek S. Mongold MD.
Somatoform Disorder NOS Derek S. Mongold MD. DSM-IV TR Criteria This Category includes disorders with somatoform symptoms that do not meet the criteria.
Primary Insomnia Derek S. Mongold MD. DSM-IV TR Criteria A. The predominant complaint is difficulty initiating or maintaining sleep, or nonrestorative.
Schizophrenia Derek S. Mongold MD. Citation American Psych, A. (2000). Diagnostic and statistical manual of mental disorders, dsm-iv-tr.. (4th ed. ed.).
Disorder of Written Expression Derek S. Mongold MD.
Sexual Dysfunction Due to a General Medical Condition Derek S. Mongold MD.
Bipolar I Disorder Derek S. Mongold MD.
PSY 436 Instructor: Emily Bullock Yowell, Ph.D.
Anxiety Disorder Due to a Generalized Medical Condition
Mixed Receptive-Expressive Language Disorder
Dissociative Fugue Derek S. Mongold MD.
Posttraumatic Stress Disorder
Substance Related Disorders
Sleep Disorder Due to a General Medical Condition
Schizophrenia and Substance Use Disorders
Rett’s Disorder Derek S. Mongold MD.
PSY 6669 Behavioral Pathology
Bipolar Disorder and Substance Use Disorders
Rumination Disorder Derek S. Mongold MD.
Feeding Disorder of Infancy or Early Childhood
DSM-IV-TR, APA, 2000 Criteria for Substance Dependence:
Stereotypic Movement Disorder
Separation Anxiety Disorder
Attention-Deficit/Hyperactivity Disorder
Addictive disorders in ICD-11 beta - Substance Use -
Reactive Attachment Disorder
Autistic Disorder Derek S. Mongold MD.
Developmental Coordination Disorder
Stuttering Disorder Derek S. Mongold MD.
Childhood Disintegrative Disorder
Pica Derek S. Mongold MD.
Selective Mutism Derek S. Mongold MD.
Office of Aerospace. Medicine
Conduct Disorder Derek S. Mongold MD.
Asperger’s Disorder Derek S. Mongold MD.
Chronic Motor or Vocal Tic Disorder
Mathematics Disorder Derek S. Mongold MD.
Tourette’s Disorder Derek S. Mongold MD.
Encopresis Derek S. Mongold MD.
Oppositional Defiant Disorder
Mental Retardation Criteria
Presentation transcript:

Substance-Induced Anxiety Disorder Derek S. Mongold MD

DSM-IV TR Criteria A. Prominent anxiety, Panic Attacks, or obsessions or compulsions predominate in the clinical picture. B. There is evidence from the history, physical examination, or laboratory findings of either (1) or (2): (1) the symptoms in Criterion A developed during, or within 1 month of, Substance Intoxication or Withdrawal (1) the symptoms in Criterion A developed during, or within 1 month of, Substance Intoxication or Withdrawal (2) medication use is etiologically related to the disturbance (2) medication use is etiologically related to the disturbance C. The disturbance is not better accounted for by an Anxiety Disorder that is not substance induced. Evidence that the symptoms are better accounted for by an Anxiety Disorder that is not substance induced might include the following: the symptoms precede the onset of the substance use (or medication use); the symptoms persist for a substantial period of time (e.g., about a month) after the cessation of acute withdrawal or severe intoxication or are substantially in excess of what would be expected given the type or amount of the substance used or the duration of use; or there is other evidence suggesting the existence of an independent non-substance-induced Anxiety Disorder (e.g., a history of recurrent non-substance-related episodes). D. The disturbance does not occur exclusively during the course of a Delirium. E. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.

DSM-IV TR Criteria Note: This diagnosis should be made instead of a diagnosis of Substance Intoxication or Substance Withdrawal only when the anxiety symptoms are in excess of those usually associated with the intoxication or withdrawal syndrome and when the anxiety symptoms are sufficiently severe to warrant independent clinical attention. Code [Specific Substance]-Induced Anxiety Disorder Alcohol; Amphetamine (or Amphetamine-Like Substance); Caffeine; Cannabis; Cocaine; Hallucinogen; Inhalant; Phencyclidine (or Phencyclidine-Like Substance); Sedative, Hypnotic, or Anxiolytic; Other [or Unknown] Substance)

DSM-IV TR Criteria Specify if: With Generalized Anxiety: if excessive anxiety or worry about a number of events or activities predominates in the clinical presentation With Panic Attacks: if Panic Attacks predominate in the clinical presentation With Obsessive-Compulsive Symptoms: if obsessions or compulsions predominate in the clinical presentation With Phobic Symptoms: if phobic symptoms predominate in the clinical presentation Specify if: With Onset During Intoxication: if the criteria are met for Intoxication with the substance and the symptoms develop during the intoxication syndrome With Onset During Withdrawal: if criteria are met for Withdrawal from the substance and the symptoms develop during, or shortly after, a withdrawal syndrome

Citation American Psych, A. (2000). Diagnostic and statistical manual of mental disorders, dsm-iv-tr.. (4th ed. ed.). Arlington VA: American Psychiatric Publishing, Inc.